Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-2828 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-2828, RRID:AB_792527
- Product name
- Goat Polyclonal UCP1 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Goat
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/ml
- Storage
- Store at -20C. Avoid freeze-thaw cycles.
Submitted references Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.
Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human.
Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity.
Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity.
Liu W, Singh R, Choi CS, Lee HY, Keramati AR, Samuel VT, Lifton RP, Shulman GI, Mani A
The Journal of biological chemistry 2012 Mar 2;287(10):7213-23
The Journal of biological chemistry 2012 Mar 2;287(10):7213-23
Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human.
Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerbäck S, Schrauwen P, Spiegelman BM
Cell 2012 Jul 20;150(2):366-76
Cell 2012 Jul 20;150(2):366-76
Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity.
Ishigaki Y, Katagiri H, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Gao J, Ishihara H, Shimosegawa T, Sakoda H, Asano T, Oka Y
Diabetes 2005 Feb;54(2):322-32
Diabetes 2005 Feb;54(2):322-32
Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity.
Ishigaki Y, Katagiri H, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Gao J, Ishihara H, Shimosegawa T, Sakoda H, Asano T, Oka Y
Diabetes 2005 Feb;54(2):322-32
Diabetes 2005 Feb;54(2):322-32
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: UCP1 Antibody [NB100-2828] - staining of Human Adipose lysate (35ug protein in RIPA buffer). Detected by chemiluminescence.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: UCP1 Antibody [NB100-2828] - (1 ug/mL) staining of Rat Adipose (A) and (0.5 ug/mL) Skeletal Muscle (B) lysate (35 ug protein in RIPA buffer). Detected by chemiluminescence.